Acquisition Potential The company was acquired by Greenbrook TMS Inc. in September 2021, indicating a larger corporate backing and potential access to broader distribution channels, enterprise sales teams, and expanded TMS network opportunities for cross-sell and strategic partnerships.

MarketPositioning As a small practice with 2-10 employees focused on dTMS therapy across depression, OCD, and anxiety, there is a clear pathway to upsell additional patient access services, referral networks, and technology integrations that scale with a larger parent organization.

ExpansionSynergy Post-acquisition integration with Greenbrook TMS could enable shared marketing, larger regional deployments, and access to a broader payer mix, suggesting opportunities for sales outreach to other Greenbrook-associated clinics or to complement their national footprint.

DigitalReach The existing tech stack (WordPress, HubSpot, Google Analytics, YouTube, social), combined with a measurable online presence, presents opportunities to offer scaled Martech solutions, patient engagement tools, or expanded digital marketing services to improve lead generation and conversion.

DiagnosticsAndPayments With a revenue range of $1M-$10M and a focus on FDA-cleared dTMS, there is potential to propose financing options, broader treatment bundles, and payer-aligned programs to optimize patient access and accelerate revenue growth across expanded markets.